Abstract
Four different mutations in the GTP cyclohydrolase I gene were found (P199L, M211V, IVS5+1G>A, G203R) in 6 out of 33 families with dopa-responsive dystonia. A splice mutation (IVS5+1G>A) located at the border of exon 5 to intron 5 was found in one of these families. Three members of the family carry the IVS5+1G>A mutation on one allele, inherited from the father to the daughter and son. Examination of the mRNA showed an exon 5 skipping that results in a reduction of enzyme activity in cultured fibroblasts to 4–17% compared to controls. The father and daughter never had clinical symptoms of dopa-responsive dystonia. The son was symptomatic at the age of 3 years and was treated successfully with L-dopa/carbidopa. After 20 years this therapy was terminated and for the next 6 years he was free of symptoms. With increased motoric activity, symptoms reappeared and the therapy was reintroduced.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
Bandmann O, Nygaard TG, Surtees R, Marsden CD, Wood NW, Harding AE (1996) Dopa-responsive dystonia in British patients—new mutations of the GTP cyclohydrolase I gene and evidence for genetic heterogeneity. Hum Mol Genet 5(3): 403-406.
Bandmann O, Valente EM, Holmans P, et al (1998) Dopa-responsive dystonia—a clinical and molecular genetic study. Ann Neurol 44(4): 649-656.
Bonafé L, Thöny B, Leimbacher W, Kierat L, Blau N. Diagnosis of dopa-responsive dystonia and other tetrahydrobiopterin disorders by the study of biopterin metabolism in fibroblasts. Clin Chem, 47: 477-485.
Blau N, Thöny B, Dianzani I (2000) DIOMDB: database of mutations causing tetrahydrobiopterin deficiency (http://www.bh4.org/biomdbl.html).
Blau N, Thöny B, Cotton RGH, Hyland K (2001) Disorders of tetrahydrobiopterin and related biogenic amines. In: Scriver CR, Beaudet AL, Sly WS, Valle D, assoc. eds; Childs B, Vogelstein B, eds. The Metabolic and Molecular Bases of Inherited Disease, 8th edn. New York: McGraw-Hill, 1275-1776.
Bräutigam C, Wevers RA, Jensen RJT, et al (1998) Biochemical hallmarks of tyrosine hydroxylase deficiency. Clin Chem 44: 1897-1904.
Furukawa Y, Shimadzu M, Rajput AH, (1996) GTP cyclohydrolase I gene mutations in hereditary progressive and dopa-responsive dystonia. Ann Neurol 39(5): 609-617.
Görke B, Bartholomé K (1990) Biochemical and neurophysiological investigation in two forms of Segawa's disease. Neuropediatrics 21: 3-8.
Gütlich M, Jaeger E, Rucknagel KP, et al (1994) Human GTP cyclohydrolase I: only one out of three cDNA isoforms gives rise to the active enzyme. Biochem J 302: 215-221.
Hirano M, Tamaru Y, Nagai Y, Ito H, Imai T, Ueno S (1995) Exon skipping caused by a base substitution at a splice site in the GTP cyclohydrolase I gene in a Japanese family with hereditary progressive dystonia/dopa-responsive dystonia. Biochem Biophys Res Commun 213(2): 645-651.
Ichinose H, Ohye T, Takahashi E, et al (1994) Hereditary progressive dystonia with marked diurnal fluctuation caused by mutation in the GTP cyclohydrolase I gene. Nature Genetics 8: 236-241.
Ichinose H, Ohye T, Matsuda Y, et al (1995) Characterization of mouse and human GTP cyclohydrolase I genes—mutations in patients with GTP cyclohydrolase I deficiency. J Biol Chem 270(17): 10062-10071.
Ichinose H, Suzuki T, Inagaki H, Ohye T, Nagatsu T (1999) Molecular genetics of dopa-responsive dystomia. Biol Chem 380(12): 1355-1364.
Knappskog PM, Flatmark T, Mallet J, Lüdecke B, Bartholomé K (1995) Recessively inherited L-DOPA-responsive dystonia caused by point mutation (Q381K) in the tyrosine hydroxylase gene. Hum Mol Genet 4: 1209.
Lüdecke B, Bartholomé K (1995) Frequent sequence variant in the human tyrosine hydroxylase gene. Hum Genet 95: 716.
Lüdecke B, Dworniczak B, Bartholomé K (1995) A point mutation in the tyrosine hydroxylase gene associated with Segawa's syndrome. Hum Genet 93: 123.
Nagatsu T, Levitt M, Udenfriend S (1964) Tyrosine hydroxylase. The initial step in norepinephrine biosynthesis. J Biol Chem 239: 2910-2917.
Nygaard TG, Marsden CD, Fahn S (1991) Dopa-responsive dystonia: long-term treatment response and prognosis. Neurology 41: 174.
Ozelius LJ, Breakfield XO (1994) Co-factor insufficiency in dystonia-Parkinsonian syndrome. Nature Genetics 8: 207-209.
Sanger F, Nickler S, Coulson AR (1977) DNA sequencing with chain terminating inhibitors. Proc Natl Acad Sci USA 74: 5463-5467.
Tassin J, Durr A, Bonnet AM, et al (2000) Levodopa-responsive dystonia: GTP cyclohydrolase I or parkin mutations? Brain 123(pt 6): 1112-1121.
Thöny B, Blau N (1997) Mutations in the GTP cyclohydrolase I and 6-pyruvoyl-tetrahydropterin synthase genes. Hum Mutat 10: 11-20.
Thöny B, Auerbach G, Blau N (2000) Tetrahydrobiopterin biosynthesis, regeneration, and functions. Biochem J 347: 1-26.
Togari A, Ichinose H, Matsumoto S, Fujita K, Nagatsu T (1992) Multiple mRNA forms of human GTP cyclohydrolase I. Biochem Biophys Res Commun 187: 359-365.
Wong C, Dowling CE, Saiki RK, Higuchi RG, Ehrlich HA, Kazazian HH (1987) Characterization of β-thalassaemia mutations using direct genomic sequencing of amplified single copy DNA. Nature 330: 384.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Skrygan, M., Bartholomé, B., Bonafé, L. et al. A splice mutation in the GTP cyclohydrolase I gene causes dopa-responsive dystonia by exon skipping. J Inherit Metab Dis 24, 345–351 (2001). https://doi.org/10.1023/A:1010544316387
Issue Date:
DOI: https://doi.org/10.1023/A:1010544316387